{"Title": "Asymmetrically Substituted Quadruplex-Binding Naphthalene Diimide Showing Potent Activity in Pancreatic Cancer Models", "Year": 2020, "Source": "ACS Med. Chem. Lett.", "Volume": "11", "Issue": 8, "Art.No": null, "PageStart": 1634, "PageEnd": 1644, "CitedBy": 0, "DOI": "10.1021/acsmedchemlett.0c00317", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85090902506&origin=inward", "Abstract": "Copyright \u00a9 2020 American Chemical Society.Targeting of genomic quadruplexes is an approach to treating complex human cancers. We describe a series of tetra-substituted naphthalene diimide (ND) derivatives with a phenyl substituent directly attached to the ND core. The lead compound (SOP1812) has 10 times superior cellular and in vivo activity compared with previous ND compounds and nanomolar binding to human quadruplexes. The pharmacological properties of SOP1812 indicate good bioavailability, which is consistent with the in vivo activity in xenograft and genetic models for pancreatic cancer. Transcriptome analysis shows that it down-regulates several cancer gene pathways, including Wnt/\u03b2-catenin signaling.", "AuthorKeywords": ["naphthalene diimide derivative", "pancreatic cancer", "quadruplex", "transcriptome", "xenograft"], "IndexKeywords": null, "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-85090902506", "SubjectAreas": [["Biochemistry", "BIOC", "1303"], ["Drug Discovery", "PHAR", "3002"], ["Organic Chemistry", "CHEM", "1605"]], "AuthorData": {"57201287173": {"Name": "Ahmed A.A.", "AuthorID": "57201287173", "AffiliationID": "60022148", "AffiliationName": "School of Pharmacy, University College London"}, "7006304705": {"Name": "Angell R.", "AuthorID": "7006304705", "AffiliationID": "60022148", "AffiliationName": "School of Pharmacy, University College London"}, "6506394982": {"Name": "Oxenford S.", "AuthorID": "6506394982", "AffiliationID": "60022148", "AffiliationName": "School of Pharmacy, University College London"}, "35820006900": {"Name": "Neidle S.", "AuthorID": "35820006900", "AffiliationID": "60022148", "AffiliationName": "School of Pharmacy, University College London"}, "57218952401": {"Name": "Worthington J.", "AuthorID": "57218952401", "AffiliationID": "125118226", "AffiliationName": "Axis Bio Discovery Services, Ltd."}, "57218950534": {"Name": "Williams N.", "AuthorID": "57218950534", "AffiliationID": "125118226", "AffiliationName": "Axis Bio Discovery Services, Ltd."}, "57194038784": {"Name": "Barton N.", "AuthorID": "57194038784", "AffiliationID": "60112157", "AffiliationName": "Sygnature Discovery Limited"}, "57218957883": {"Name": "Fowler T.G.", "AuthorID": "57218957883", "AffiliationID": "60112157", "AffiliationName": "Sygnature Discovery Limited"}, "57218955603": {"Name": "O'Flynn D.E.", "AuthorID": "57218955603", "AffiliationID": "60112157", "AffiliationName": "Sygnature Discovery Limited"}, "6506522444": {"Name": "Sunose M.", "AuthorID": "6506522444", "AffiliationID": "60112157", "AffiliationName": "Sygnature Discovery Limited"}, "57201748987": {"Name": "McConville M.", "AuthorID": "57201748987", "AffiliationID": "60112157", "AffiliationName": "Sygnature Discovery Limited"}, "56123225400": {"Name": "Vo T.", "AuthorID": "56123225400", "AffiliationID": "60012387", "AffiliationName": "Department of Chemistry, Center for Biotechnology and Drug Design, Georgia State University"}, "35402558500": {"Name": "Wilson W.D.", "AuthorID": "35402558500", "AffiliationID": "60012387", "AffiliationName": "Department of Chemistry, Center for Biotechnology and Drug Design, Georgia State University"}, "56463594700": {"Name": "Karim S.A.", "AuthorID": "56463594700", "AffiliationID": "60031990, 60012754", "AffiliationName": "Cancer Research UK, Beatson Institute"}, "20434051500": {"Name": "Morton J.P.", "AuthorID": "20434051500", "AffiliationID": "60001490", "AffiliationName": "Institute of Cancer Sciences, University of Glasgow"}}}